Digital Health Industry Analysis

See the market the way insiders do

Digital health is a noisy market. Every week brings a new funding announcement, a new FDA clearance, a new platform claiming to reinvent care delivery. For the teams who have to make real decisions inside that noise — which segment to enter, which competitor to worry about, which regulatory pathway to plan for — press coverage is not enough. You need someone who has watched this industry long enough to tell durable shifts from passing hype.

That is what mHealth Zone industry analysis provides. Our research practice is built on the same archive that powers our journalism: more than four hundred recorded conversations with founders, clinicians, payers, regulators and investors, stretching back to the earliest days of mobile health. When we map a market, we are not paraphrasing press releases. We are drawing on years of first-hand testimony about what actually worked, what quietly failed and why.

What we deliver

Every engagement is scoped to the decision you need to make, but most of our work falls into four formats:

• Market landscapes. A structured map of a segment — remote patient monitoring, digital therapeutics, virtual-first primary care, clinical AI — covering the key players, business models, funding flows and adoption barriers.
• Competitive briefings. Deep teardowns of specific competitors: product capabilities, pricing signals, regulatory status, partnership strategy and the gaps a challenger can exploit.
• Regulatory trackers. Ongoing monitoring of FDA digital health guidance, EU MDR and AI Act implications, reimbursement policy and state telehealth rules, translated into plain-language impact assessments for your roadmap.
• Quarterly trend reports. A recurring, subscription-style briefing that connects the quarter's funding, M&A, clearances and clinical evidence into a coherent picture of where the market is heading.

How we work

We start every project with a working session to understand the decision at stake — not just the topic. A market landscape built to support a fundraise looks different from one built to support a build-versus-buy decision, and pretending otherwise wastes your budget. From there we combine desk research, our proprietary interview archive and fresh expert conversations arranged specifically for your project.

Deliverables arrive as decision-ready documents: clearly structured, honestly caveated and written in plain English rather than consultant-speak. Every report ends with a section titled "What we would do in your position" — because analysis that stops short of a recommendation is only half finished.

• Kickoff working session to define the decision, scope and timeline
• Primary interviews with operators and clinicians, not just secondary sources
• Draft review checkpoint so findings never arrive as a surprise
• Final readout call with your team, including open Q&A

Who hires us

Our clients include digital health vendors validating a new product line, hospital innovation teams evaluating build-or-partner options, investors running diligence on mHealth deals, and marketing leaders who need credible market context for board decks and analyst conversations. If your decision touches health apps, telemedicine, wearables, connected devices or AI in care delivery, it is squarely inside our coverage universe.

Engagements typically run from a two-week rapid briefing to a quarterly retainer. Wherever you land on that spectrum, you get the same standard: research we would be willing to publish under our own masthead.

"Analysis that stops short of a recommendation is only half finished." — the principle behind every mHealth Zone report.

Start with a scoping call

Tell us the decision you are facing and we will come back within two business days with a proposed scope, timeline and fixed price. No obligation, no generic sales deck — just a concrete plan for getting you the clarity you need.

Request a scoping call